$NCSM

ADVENT INTERNATIONAL, L.P. (Advent-NCS Acquisition Limited Partnership) sold 1,478,426 shares of NCSM (indirect holdings)

ADVENT INTERNATIONAL, L.P. sold 1,478,426 indirectly-held shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01. Filed jointly with ADVENT INTERNATIONAL GP, LLC (10% owner) and Advent-NCS Acquisition Limited Partnership (10% owner).

Original reporting
SEC EDGAR · ADVENT INTERNATIONAL, L.P., ADVENT INTERNATIONAL GP, LLC, Advent-NCS Acquisition Limited Partnership
Published Sep 1, 2026, 10:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 11:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Bearish
medium confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMBearishLow
01

Why it matters

The sale reduces Advent International's ownership to zero, potentially affecting voting power and signaling to the market.

02

Market read

Insider sell-off may prompt short-term price pressure; relevance limited to NCSM investors.

03

What to watch

The transaction was at market price; no disclosed price or valuation context.

Relevance 4/10Novelty 4/10Timing: 2026-09-01 filing

Background

Form 4 filings provide the first public record of insider transactions.

Company-level read

Ticker impact

$NCSMBearishMedium confidence
Context

SEC Form 4 disclosed Advent International sold 1,478,426 shares of NCS Multistage Holdings, reducing its stake to zero.

Expected impact

possible modest decline in NCSM price over the next few days

Evidence & confidence

Large insider stake sold without a 10b5-1 plan; market may interpret as negative, but size relative to float unknown.

Market effects

Minimal impact on the broader biotech/clinical-stage sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be a portfolio rebalancing rather than a lack of confidence.

Key entities

  • Advent International, L.P.

    Private equity firm reporting the sale.

  • NCS Multistage Holdings, Inc.

    Issuer of the shares sold.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).